Skip to main content
NCBI home page
Epidemiology and Infection logoLink to Epidemiology and Infection
. 1989 Jun;102(3):401–412. doi: 10.1017/s0950268800030119

Inhibitory substances produced by Streptococcus salivarius and colonization of the upper respiratory tract with group A streptococci.

W C Huskins 1, E L Kaplan 1
PMCID: PMC2249463  PMID: 2500355

Abstract

It has been proposed that inhibitory substances produced by viridans streptococci colonizing the upper respiratory tract aid in eradication of established group A streptococcal colonization of that site. We studied the prevalence of inhibitory-substance producing strains of Streptococcus salivarius in throat cultures from three groups of children: 16 children with persistently positive throat cultures for group A streptococci despite receiving recommended therapeutic courses of antibiotics (group I), 26 children from whom group A streptococci were eradicated from the upper respiratory tract by antibiotic therapy (group II), and 18 children who never harboured group A streptococci in their upper respiratory tract during the study period (group III). An in vitro deferred antagonism method was employed to detect inhibitory substances; 5233 strains of S. salivarius were examined. Strains of S. salivarius producing inhibitory substances were isolated from 76-88% of the children in each group on at least one occasion. However, only a small percentage of subjects in each group harboured strains producing these substances in every throat culture. The mean total percentage of S. salivarius strains producing inhibitory substances was 21.8% in children in group I, 22.4% in children in group II, and 16.4% in children in group III; these percentages were not statistically different (P greater than 0.1). In this study, we could not confirm a significant role for inhibitory substances produced by S. salivarius in the eradication of group A streptococci from the upper respiratory tract of colonized individuals.

Full text

PDF
401

Images in this article

405Fig. 1
on p.405
406Fig. 2
on p.406

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brook I. The role of beta-lactamase-producing bacteria in the persistence of streptococcal tonsillar infection. Rev Infect Dis. 1984 Sep-Oct;6(5):601–607. doi: 10.1093/clinids/6.5.601. [DOI] [PubMed] [Google Scholar]
  2. Crowe C. C., Sanders W. E., Jr, Longley S. Bacterial interference. II. Role of the normal throat flora in prevention of colonization by group A Streptococcus. J Infect Dis. 1973 Oct;128(4):527–532. doi: 10.1093/infdis/128.4.527. [DOI] [PubMed] [Google Scholar]
  3. Dajani A. S., Tom M. C., Law D. J. Viridins, bacteriocins of alpha-hemolytic streptococci: isolation, characterization, and partial purification. Antimicrob Agents Chemother. 1976 Jan;9(1):81–88. doi: 10.1128/aac.9.1.81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dempster R. P., Tagg J. R. The production of bacteriocin-like substances by the oral bacterium Streptococcus salivarius. Arch Oral Biol. 1982;27(2):151–157. doi: 10.1016/0003-9969(82)90136-4. [DOI] [PubMed] [Google Scholar]
  5. Facklam R. R. Physiological differentiation of viridans streptococci. J Clin Microbiol. 1977 Feb;5(2):184–201. doi: 10.1128/jcm.5.2.184-201.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Grahn E., Holm S. E. Bacterial interference in the throat flora during a streptococcal tonsillitis outbreak in an apartment house area. Zentralbl Bakteriol Mikrobiol Hyg A. 1983 Nov;256(1):72–79. [PubMed] [Google Scholar]
  7. Kaplan E. L., Couser R., Huwe B. B., McKay C., Wannamaker L. W. Significance of quantitative salivary cultures for group A and non-group A and non-group A beta-hemolytic streptococci in patients with pharyngitis and in their family contacts. Pediatrics. 1979 Dec;64(6):904–912. [PubMed] [Google Scholar]
  8. Kaplan E. L., Gastanaduy A. S., Huwe B. B. The role of the carrier in treatment failures after antibiotic for group A streptococci in the upper respiratory tract. J Lab Clin Med. 1981 Sep;98(3):326–335. [PubMed] [Google Scholar]
  9. Malke H., Starke R., Jacob H. E., Köhler W. Bacteriocine-like activity of group-A streptococci due to the production of peroxide. J Med Microbiol. 1974 Aug;7(3):367–374. doi: 10.1099/00222615-7-3-367. [DOI] [PubMed] [Google Scholar]
  10. Sanders C. C., Nelson G. E., Sanders W. E., Jr Bacterial interference. IV. Epidemiological determinants of the antagonistic activity of the normal throat flora against group A streptococci. Infect Immun. 1977 May;16(2):599–603. doi: 10.1128/iai.16.2.599-603.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Sanders C. C., Sanders W. E., Jr Enocin: an antibiotic produced by Streptococcus salivarius that may contribute to protection against infections due to group A streptococci. J Infect Dis. 1982 Nov;146(5):683–690. doi: 10.1093/infdis/146.5.683. [DOI] [PubMed] [Google Scholar]
  12. Sanders C. C., Sanders W. E., Jr, Harrowe D. J. Bacterial interference: effects of oral antibiotics on the normal throat flora and its ability to interfere with group A streptococci. Infect Immun. 1976 Mar;13(3):808–812. doi: 10.1128/iai.13.3.808-812.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Sanders E. Bacterial interference. I. Its occurrence among the respiratory tract flora and characterization of inhibition of group A streptococci by viridans streptococci. J Infect Dis. 1969 Dec;120(6):698–707. doi: 10.1093/infdis/120.6.698. [DOI] [PubMed] [Google Scholar]
  14. Smith T. D., Huskins W. C., Kim K. S., Kaplan E. L. Efficacy of beta-lactamase-resistant penicillin and influence of penicillin tolerance in eradicating streptococci from the pharynx after failure of penicillin therapy for group A streptococcal pharyngitis. J Pediatr. 1987 May;110(5):777–782. doi: 10.1016/s0022-3476(87)80023-9. [DOI] [PubMed] [Google Scholar]
  15. Tagg J. R., Dajani A. S., Wannamaker L. W. Bacteriocins of gram-positive bacteria. Bacteriol Rev. 1976 Sep;40(3):722–756. doi: 10.1128/br.40.3.722-756.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Tagg J. R., Pybus V., Phillips L. V., Fiddes T. M. Application of inhibitor typing in a study of the transmission and retention in the human mouth of the bacterium Streptococcus salivarius. Arch Oral Biol. 1983;28(10):911–915. doi: 10.1016/0003-9969(83)90086-9. [DOI] [PubMed] [Google Scholar]
  17. Tagg J. R., Wong H. K. Inhibitor production by group-G streptococci of human and of animal origin. J Med Microbiol. 1983 Nov;16(4):409–415. doi: 10.1099/00222615-16-4-409. [DOI] [PubMed] [Google Scholar]

Articles from Epidemiology and Infection are provided here courtesy of Cambridge University Press

RESOURCES